These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18978312)

  • 1. Effects of cannabis use on outcomes of psychotic disorders: systematic review.
    Zammit S; Moore TH; Lingford-Hughes A; Barnes TR; Jones PB; Burke M; Lewis G
    Br J Psychiatry; 2008 Nov; 193(5):357-63. PubMed ID: 18978312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
    Moore TH; Zammit S; Lingford-Hughes A; Barnes TR; Jones PB; Burke M; Lewis G
    Lancet; 2007 Jul; 370(9584):319-28. PubMed ID: 17662880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
    Hides L; Dawe S; Kavanagh DJ; Young RM
    Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
    Hides L; Kavanagh DJ; Dawe S; Young RM
    Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
    Toftdahl NG; Nordentoft M; Hjorthøj C
    J Dual Diagn; 2016; 12(2):129-36. PubMed ID: 27070732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
    Reid S; Bhattacharyya S
    Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
    Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does change in cannabis use in established psychosis affect clinical outcome?
    Barrowclough C; Emsley R; Eisner E; Beardmore R; Wykes T
    Schizophr Bull; 2013 Mar; 39(2):339-48. PubMed ID: 22037770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.
    Verdoux H; Gindre C; Sorbara F; Tournier M; Swendsen JD
    Psychol Med; 2003 Jan; 33(1):23-32. PubMed ID: 12537033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.
    Madigan K; Brennan D; Lawlor E; Turner N; Kinsella A; O'Connor JJ; Russell V; Waddington JL; O'Callaghan E
    Schizophr Res; 2013 Jan; 143(1):138-42. PubMed ID: 23187069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
    Kraan T; Velthorst E; Koenders L; Zwaart K; Ising HK; van den Berg D; de Haan L; van der Gaag M
    Psychol Med; 2016 Mar; 46(4):673-81. PubMed ID: 26568030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders.
    Dekker N; Linszen DH; De Haan L
    Psychopathology; 2009; 42(6):350-60. PubMed ID: 19752588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis.
    van der Meer FJ; Velthorst E; Meijer CJ; Machielsen MW; de Haan L
    Curr Pharm Des; 2012; 18(32):5036-44. PubMed ID: 22716158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.